Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-23-005705
Filing Date
2023-03-02
Accepted
2023-03-02 07:13:18
Documents
91
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K agle-20221231.htm   iXBRL 10-K 4335350
2 EX-10.17 agle-ex10_17.htm EX-10 261796
3 EX-10.21 agle-ex10_21.htm EX-10 40330
4 EX-10.22 agle-ex10_22.htm EX-10 114410
5 EX-10.23 agle-ex10_23.htm EX-10 135834
6 EX-10.24 agle-ex10_24.htm EX-10 156603
7 EX-21.1 agle-ex21_1.htm EX-21 25768
8 EX-23.1 agle-ex23_1.htm EX-23 3143
9 EX-31.1 agle-ex31_1.htm EX-31 17929
10 EX-31.2 agle-ex31_2.htm EX-31 17786
11 EX-32.1 agle-ex32_1.htm EX-32 9736
12 EX-32.2 agle-ex32_2.htm EX-32 9704
13 GRAPHIC img43784786_0.jpg GRAPHIC 43074
14 GRAPHIC img43784786_1.jpg GRAPHIC 15684
  Complete submission text file 0000950170-23-005705.txt   15286070

Data Files

Seq Description Document Type Size
15 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT agle-20221231_lab.xml EX-101.LAB 598289
16 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT agle-20221231_cal.xml EX-101.CAL 71160
17 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT agle-20221231_def.xml EX-101.DEF 244190
18 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT agle-20221231.xsd EX-101.SCH 70747
19 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT agle-20221231_pre.xml EX-101.PRE 427306
85 EXTRACTED XBRL INSTANCE DOCUMENT agle-20221231_htm.xml XML 3078545
Mailing Address 805 LAS CIMAS PARKWAY SUITE 100 AUSTIN TX 78746
Business Address 805 LAS CIMAS PARKWAY SUITE 100 AUSTIN TX 78746 (512) 942-2935
Aeglea BioTherapeutics, Inc. (Filer) CIK: 0001636282 (see all company filings)

EIN.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37722 | Film No.: 23696398
SIC: 2834 Pharmaceutical Preparations